Over 10 years we help companies reach their financial and branding goals. Maxbizz is a values-driven consulting agency dedicated.

Gallery

Contact

+1-800-456-478-23

411 University St, Seattle

maxbizz@mail.com

Sona Nanotech to Arrange Private Placement Financing

Sona Nanotech to Arrange Private Placement Financing

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company”, “Sona”) is pleased to announce that it plans to raise up to $1,500,000 through a private placement financing (the “Financing”) of up to 6,000,000 common shares of Sona (each, a “Share”) at a price of $0.25 per Share (the “Offering Price”). Insiders and certain other existing shareholders of Sona may also subscribe for Shares under the Financing.

Aero Energy and Fortune Bay Announce Completion of Drilling Program on the Murmac Uranium Project

Aero Energy and Fortune Bay Announce Completion of Drilling Program on the Murmac Uranium Project

HALIFAX, NS July 24, 2024 – Fortune Bay Corp. (TSXV:FOR, FWB:5QN, OTCQB: FTBYF) (“Fortune Bay” or the “Company”) is pleased to announce completion of the 2024 summer drill program on the Murmac Uranium Project (“Murmac” or the “Project”), located in northern Saskatchewan near Uranium City. The program was designed to test regional targets across the Project […]

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce that a detailed biomarker analysis of the recently reported pre-clinical melanoma study conducted at Dalhousie

Sona’s Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study

Sona Nanotech Inc. (CSE: SONA)(OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce that its targeted hyperthermia therapy (“THT”) demonstrated positive results in a second preclinical cancer model. Findings just presented at the 2024 STING & TLR Targeted Therapies Summit for immunotherapies in San Diego, California, show that Sona’s THT achieved responses in a preclinical melanoma model equal to that which was recently reported from its triple negative breast cancer study. THT effectively treated melanoma tumors in all animals when administered on its own. Further, when THT was combined with doses of interleukin-2 (“IL-2”), a standard immunotherapy, a synergistic effect was shown whereby greater treatment response, measured by tumor volume reduction, was achieved in comparison to either approach alone.

Aero Energy and Fortune Bay Intersect Strong Radioactivity in Second Drill Hole at the Murmac Uranium Project

Aero Energy and Fortune Bay Intersect Strong Radioactivity in Second Drill Hole at the Murmac Uranium Project

HALIFAX, NS June 25, 2024 – Fortune Bay Corp. (TSXV:FOR, FWB:5QN, OTCQB: FTBYF) (“Fortune Bay” or the “Company”) is pleased to announce the intersection of highly elevated radioactivity in the second drill hole (M24-017) of its 2024 exploration drilling program on the Murmac Uranium Project (“Murmac” or the “Project”), located in northern Saskatchewan. An average of 1,309 […]

Sona’s Therapy Shows Significant Preclinical Efficacy in Second Cancer

Sona’s Therapy Shows Significant Preclinical Efficacy in Second Cancer

Sona Nanotech Inc. (CSE: SONA)(OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce that its targeted hyperthermia therapy (“THT”) demonstrated positive results in a second preclinical cancer model. Findings just presented at the 2024 STING & TLR Targeted Therapies Summit for immunotherapies in San Diego, California, show that Sona’s THT achieved responses in a preclinical melanoma model equal to that which was recently reported from its triple negative breast cancer study. THT effectively treated melanoma tumors in all animals when administered on its own. Further, when THT was combined with doses of interleukin-2 (“IL-2”), a standard immunotherapy, a synergistic effect was shown whereby greater treatment response, measured by tumor volume reduction, was achieved in comparison to either approach alone.

Aero Energy and Fortune Bay Announce Drilling Underway at the Murmac Uranium Project, Athabasca Basin, Saskatchewan

Aero Energy and Fortune Bay Announce Drilling Underway at the Murmac Uranium Project, Athabasca Basin, Saskatchewan

HALIFAX, NS June 12, 2024 – Fortune Bay Corp. (TSXV:FOR) (FWB:5QN) (OTCQB:FTBYF) (“Fortune Bay” or the “Company”) is pleased to announce the commencement of drilling at its Murmac Uranium Project (“Murmac” or the “Project”) on the northern margin of the Athabasca Basin, Saskatchewan. The drilling program is being funded by Aero Energy Limited (TSXV: AERO) (OTC […]

Fortune Bay Announces Targets for Upcoming Drill Program at the Murmac Uranium Project

Fortune Bay Announces Targets for Upcoming Drill Program at the Murmac Uranium Project

HALIFAX, NS June 4, 2024 – Fortune Bay Corp. (TSXV:FOR) (FWB:5QN) (OTCQB:FTBYF) (“Fortune Bay” or the “Company”) is pleased to announce drill targets for its Murmac Uranium Project (“Murmac or the “Project”) located in northern Saskatchewan. A drilling program is scheduled to commence in the coming days to test up to thirteen (13) of these targets […]

Antler Gold Announces Option Agreement for the Erongo Gold Project in Namibia Is Subject to TSX-V and Shareholder Approval

Antler Gold Announces Option Agreement for the Erongo Gold Project in Namibia Is Subject to TSX-V and Shareholder Approval

Further to Antler Gold Inc.’s (TSXV: ANTL) (“Antler” or the “Company”) News Release dated May 23, 2024 (the “Erongo Gold News Release”), the transaction contemplated in the Letter of Intent between the Company and Fortress Asset Management LLC, as described in the Erongo Gold News Release, is subject to TSX-V and shareholder approval.